CN Patent

CN1460476A — 可调释药速率的阿扑吗啡舌下滴丸制剂

Assigned to Individual · Expires 2003-12-10 · 22y expired

What this patent protects

本发明提供一种用于治疗男性勃起功能障碍、女性性功能障碍及帕金森氏综合征的可调释药速率的阿扑吗啡舌下滴丸制剂，主要包含阿扑吗啡、滴丸基质、包衣材料和/或药用添加剂。阿扑吗啡的释药速率可通过选用不同的滴丸基质及其组成或包衣材料来调节。该滴丸可为单方或复方，可包衣或不包衣。滴丸包衣可糖衣或薄膜衣。全部溶散时限可为4～30分种。本发明提供的制剂制备工艺简单、质量易控、稳定性好。

USPTO Abstract

本发明提供一种用于治疗男性勃起功能障碍、女性性功能障碍及帕金森氏综合征的可调释药速率的阿扑吗啡舌下滴丸制剂，主要包含阿扑吗啡、滴丸基质、包衣材料和/或药用添加剂。阿扑吗啡的释药速率可通过选用不同的滴丸基质及其组成或包衣材料来调节。该滴丸可为单方或复方，可包衣或不包衣。滴丸包衣可糖衣或薄膜衣。全部溶散时限可为4～30分种。本发明提供的制剂制备工艺简单、质量易控、稳定性好。

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN1460476A
Jurisdiction: CN
Classification: —
Expires: 2003-12-10
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.